Paul McBarron
2007
In 2007, Paul McBarron earned a total compensation of $828K as Chief Operating Officer, Executive Vice President Finance at Cyclacel Pharmaceuticals, a 29% decrease compared to previous year.
Compensation breakdown
| Bonus | $107,854 |
|---|---|
| Option Awards | $375,143 |
| Salary | $324,804 |
| Other | $20,170 |
| Total | $827,971 |
McBarron received $375.1K in option awards, accounting for 45% of the total pay in 2007.
McBarron also received $107.9K in bonus, $324.8K in salary and $20.2K in other compensation.
Rankings
In 2007, Paul McBarron's compensation ranked 4,633rd out of 8,700 executives tracked by ExecPay. In other words, McBarron earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,633 out of 8,700 | 47th |
Division Manufacturing | 1,688 out of 3,314 | 49th |
Major group Chemicals And Allied Products | 341 out of 746 | 54th |
Industry group Drugs | 206 out of 546 | 62nd |
Industry Pharmaceutical Preparations | 148 out of 364 | 59th |
Source: SEC filing on April 2, 2008.
McBarron's colleagues
We found four more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2007.
2007
Spiro Rombotis
Cyclacel Pharmaceuticals
Chief Executive Officer
2007
Judy Chiao
Cyclacel Pharmaceuticals
Vice President Clinical Development and Regulatory Affairs
2007
Greg Reyes
Cyclacel Pharmaceuticals
Senior Vice President Research
2007
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020